Loading clinical trials...
Loading clinical trials...
A Safety Assessment of the 480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo SFA Lesions
Conditions
Interventions
480 Biomedical Bioresorbable Scaffold System
Locations
6
Australia
The Alfred
Melbourne, Australia
Universitäts Klinikum Graz
Graz, Austria
Universitaet Freiburg-Bad Krozingen
Freiburg im Breisgau, Germany
Park Hospital - Heart Center Leipzig
Leipzig, Germany
RoMed Klinikum Rosenheim
Rosenheim, Germany
Auckland City Hospital
Auckland, New Zealand
Start Date
October 1, 2011
Primary Completion Date
March 1, 2014
Completion Date
October 1, 2015
Last Updated
September 6, 2019
NCT04597307
NCT06933745
Lead Sponsor
480 Biomedical
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions